Hematopoietic cell transplantation (HCT) is a potentially curative treatment for many
hematologic and nonhematologic disorders. Graft-versus-host-disease (GVHD) in its acute …

Haploidentical donor stem cell transplantation (haplo-SCT) has made great advances in
recent decades. The granulocyte colony-stimulating factor (G-CSF)-and antithymocyte …

Chronic graft-versus-host disease (GVHD) can be associated with significant morbidity, in
part because of nonreversible fibrosis, which impacts physical functioning (eye, skin, lung …

The timing of immune-related adverse events (irAE) associated with immune checkpoint
inhibitors (ICI) is highly variable. Although the development of irAE has been associated with …

Despite the use of high-resolution molecular techniques for tissue typing, chronic graft-
versus-host disease (cGVHD) remains a major complication following allogeneic …

Abstract The National Institutes of Health Consensus criteria for chronic graft-versus-host
disease (cGVHD) diagnosis can be challenging to apply in children, making pediatric …

Chronic graft-versus-host disease (GVHD) commonly occurs after allogeneic hematopoietic
cell transplantation (HCT) despite standard prophylactic immune suppression. Intensified …

Prognostic, diagnostic or predictive biomarkers are urgently needed for assessment of
chronic graft-versus-host disease (cGvHD), a major risk for patients undergoing allogeneic …

Chronic graft-versus-host disease (cGvHD) remains a prominent barrier to allogeneic
hematopoietic stem cell transplantion as the leading cause of nonrelapse mortality and …

Chronic graft-versus-host disease (cGVHD) is a potentially life-threatening complication of
allogeneic hematopoietic stem cell transplantation. Clinical data surrounding cGVHD …